GRADUAL FILLING UP OF TB DRUG PIPELINE: HOW CAN WE PLAY OUR ROLE BETTER ?

摘要

With the introduction of streptomycin (1944), p-aminosalicylic acid (1949), isoniazid (1952), pyrazinamide (1954), cycloserine (1955), ethambutol (1962) and rifamycin (1963), as anti-tuberculosis agents, hope dawned on the gloomy world of patients of tuberculosis. By the end of the 20th century, the changing disease and patient profiles had necessitated to step-up the global hunt for better and more effective drugs in the changed scenario.